Ocean Biomedical Stock Technical Analysis

OCEA Stock   0.0005  -0.0001  -16.67%   
Market data as of the 16th of March 2026 shows Ocean Biomedical priced at 0.00 per share. Measured indicators report Semi Deviation of 29.89, risk adjusted performance of 0.1596, and Coefficient Of Variation of 530.99. The model examines historical data series to identify measurable trend characteristics. At this level, volatility clustering becomes more pronounced. Technical levels are measured against peer distributions.

Ocean Biomedical Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Ocean, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Ocean
  
Ocean Biomedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Value and price for Ocean Biomedical are related but not identical, and they can diverge across cycles. For Ocean Biomedical, key inputs include a P/B ratio of 100.67. In practice, Ocean Biomedical price is set by the continuous auction process on its listing exchange.

What if' Analysis

Running a what-if backtest on Ocean Biomedical gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Ocean Biomedical's historical reward profile was stable enough to support the current thesis.
0.00
12/16/2025
 
No Change 0.00  0.0 
In 3 months and 1 day
 
03/16/2026
0.00
An initial  0.00  allocation to Ocean Biomedical on December 16, 2025 held through today would generate 0.00 in total gains. This reflects a 0.0% total return in Ocean Biomedical in total across 90 days. Ocean Biomedical is related to or competes with Prenetics Global, Surrozen, SAB Biotherapeutics, and Pasithea Therapeutics. The list provides context for relative analysis. More

Ocean Biomedical Upside and Downside Indicators Summary

These indicators describe how Ocean Biomedical momentum evolves across recent price ranges. They compare current price to recent trend and sentiment readings.

Volatility and Risk Indicators for Ocean Biomedical Signals

Risk measures here provide context on Ocean Biomedical's return distribution and drawdown behavior. The indicators highlight how volatility has behaved across recent periods.
Mean reversion in Ocean Biomedical's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Hype
Prediction
LowEstimatedHigh
0.000.000550.03
Details
Intrinsic
Valuation
LowRealHigh
0.000.000550.03
Details
Naive
Forecast
LowNextHigh
0.0000180.000976.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-00.00080.0016
Details
A rigorous investment case for Ocean Biomedical requires more than studying its own financials. Benchmarking Ocean Biomedical's performance, valuation, and risk profile against competitors is essential to validate any investment thesis.

Technical Indicators

Ocean Biomedical Backtested Returns

Ocean Biomedical currently shows a severely unstable volatility profile across the evaluation window. It shows an Efficiency (Sharpe) Ratio of 0.21, quantifying return efficiency across 3 months. Signal processing identified twenty-nine dispersion-based indicators. Please assess metrics such as Semi Deviation of 29.89, risk-adjusted performance of 0.1596, and Coefficient Of Variation of 530.99 to validate implied volatility levels. Ocean Biomedical holds a performance score of 16 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -5.63, which alludes to a somewhat significant risk relative to the market. Returns on Ocean Biomedical are inversely related to market direction and amplified in magnitude, making it a counter-cyclical holding. Use Ocean Biomedical the relationship between the jensen alpha and maximum drawdown, to analyze future returns on Ocean Biomedical.
Auto-correlation
    
  -0.09  

Very weak reverse predictability

Ocean Biomedical exhibits very weak reverse predictability. Autocorrelation measures the degree of predictability between Ocean Biomedical time series from 16th of December 2025 to 30th of January 2026 and from 30th of January 2026 to 16th of March 2026. Persistent correlation between intervals suggests underlying momentum patterns in Ocean Biomedical that may carry forward. The measured coefficient of -0.09 means less than 9.0% of Ocean Biomedical's recent price variance traces back to prior period behavior. Given that Ocean Biomedical has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
Correlation Coefficient-0.09
Spearman Rank Test-0.03
Residual Average0.0
Price Variance0.0
Ocean Biomedical technical pink sheet analysis uses price and volume transformations to study behavior. The analysis highlights moving averages, RSI, and price correlation signals across the pink sheet cycle.
Technical analysis evaluates whether price behavior reflects available information and market structure. The focus is on repeatable price behavior and identifiable trend conditions. More Info...

Technical Analysis

Indicator
Time Period
Execute Indicator
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Ocean Biomedical volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Technical Analysis Methodology & Indicators

Technical analysis of Ocean Biomedical evaluates price structure, momentum, and volatility clustering. Support and resistance levels frame risk boundaries for observed price regimes. Ocean Biomedical has a market cap of 1.93 M.

This section for Ocean Biomedical is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on February 20th, 2026

Ocean Biomedical Technical Indicators

Technical indicators tied to Ocean Biomedical help investors translate chart behavior into a more structured framework for entry, exit, and risk control. A disciplined technical workflow helps investors separate stronger setups from noisier price action.

March 16, 2026 Daily Trend Indicators

Technical indicators tied to Ocean Biomedical help investors translate chart behavior into a more structured framework for entry, exit, and risk control. A disciplined technical workflow helps investors separate stronger setups from noisier price action.

Popular Tools for Ocean Pink Sheet analysis

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals